Mannan Pharmaceuticals Establishes Research And Development Center In Greenville County, South Carolina
In locating at the Institute for Translational Oncology Research of Greenville Health System, Mannan plans to expand its R&D team to create up to 34 new positions over the next several years.
"We are thrilled to establish operations at ITOR in Greenville, as we believe that ITOR provides an ideal environment for Mannan to develop solutions to various muscular dystrophies and metastatic cancers. Some of the most advanced cancer treatments anywhere in the world are being offered at ITOR, which provides organizations like ours with the services, technologies and facilities required to develop life-saving drugs for patients in need. We are extremely appreciative for the support we have received from the South Carolina Department of Commerce, the Greenville Area Development Corporation, Upstate Alliance and Greenville Health System in making this announcement a reality,” said Dr. Xiaohua Wu, Senior Executive with Mannan Pharmaceuticals.
Mannan Pharmaceuticals LLC is a privately held company and had been considering locations nationwide before deciding to open at ITOR, according to the company. Mannan expects to add up to three more associates in 2014 and then will continue to grow and expand its team over time, as investment and developments warrant.
"Mannan's decision to come to Greenville County is another example of our growing research and development sector - and the fact their company focuses on combatting some of the most debilitating cancers and diseases is great news for our state. We welcome them to South Carolina and celebrate the 34 new jobs they are creating in Greenville,” said Governor Nikki Haley.
"We're pleased that Mannan Pharmaceuticals LLC has chosen to locate their research and development operations here in Greenville County and appreciate the valuable roles played by Commerce, the Upstate Alliance and Greenville Health System and ITOR in making this happen. Their decision is an important affirmation of this region's continuing strategic focus on further developing the bioscience cluster here, and we welcome them to Greenville,” said Richard "Dick" Wilkerson, chairman of the Greenville Area Development Corporation.
"We want to welcome Mannan Pharmaceuticals to the Upstate and congratulate all the many partners that worked together to locate them here. We especially want to thank the members of the Upstate's Bio Task Force, particularly SC BIO, for the role they played in connecting Mannan with the resources critical to their success. Their announcement today is great testament to the strength of the Upstate's growing bioscience ecosystem,” John Lummus, President/CEO of the Upstate Alliance added.
"GHS's Clinical University and ITOR are very pleased to welcome Mannan Pharmaceuticals as the newest early stage innovation company to establish a research presence within the ITOR Innovation Zone on GHS's Memorial Campus. Mannan's focus on developing new drugs to combat cancer and muscular dystrophy makes them an excellent fit as our newest on-site private sector collaborator. We look forward to establishing a high-impact, collaborative relationship between Mannan and our clinicians and university partners, as we continually strive to improve the health of our region and enhance patient care by actively facilitating the development, implementation and widespread use of healthcare delivery advancements,” said Sam Konduros, Executive Director for the Greenville Health Research Development Corporation.
2019 Leading Metro Locations: Pacific and South-Atlantic Metros Dominate the List
2019 Top States for Doing Business: Georgia Ranks #1 Sixth Year in a Row
A Heightened Focus on Reshoring
Site Selection 2020: The Importance of “Regional Depth” with Global Reach
COVID-19 and Site Selection in the Near and Long Term
34th Annual Corporate Survey & the 16th Annual Consultants Survey